Screener
AbbVie ABBV Finance Lease Liabilities
Discontinued — last reported Q4 '25
Finance Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by AbbVie in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.
The source filing: AbbVie’s 10-K, filed February 20, 2026. Open the filing →
- Filed
- Feb 20, 2026, 2:38 PM EST
- Fiscal year
- FY2025
- Accession
- 0001551152-26-000008
FAQ
- What is AbbVie's finance lease liabilities?
- AbbVie (ABBV) reported finance lease liabilities of $22M in Q4 2025.
- How has AbbVie's finance lease liabilities changed year-over-year?
- AbbVie's finance lease liabilities decreased by 4.3% year-over-year, from $23M to $22M.
- What is the long-term trend for AbbVie's finance lease liabilities?
- Over 5 years (2020 to 2025), AbbVie's finance lease liabilities has grown at a 0.9% compound annual growth rate (CAGR), from $21M to $22M.
- What does finance lease liabilities mean?
- Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.
Ask your AI about AbbVie's finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude